RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,223,036 | +29.6% | 96,948 | -6.7% | 0.00% | 0.0% |
| Q2 2023 | $1,714,739 | -22.8% | 103,958 | -16.5% | 0.00% | 0.0% |
| Q1 2023 | $2,221,004 | +55564.3% | 124,509 | -9.1% | 0.00% | 0.0% |
| Q4 2022 | $3,990 | -99.9% | 136,991 | -38.6% | 0.00% | -50.0% |
| Q3 2022 | $5,466,000 | +420.6% | 223,131 | -11.9% | 0.00% | – |
| Q2 2022 | $1,050,000 | -52.9% | 253,241 | +30.7% | 0.00% | -100.0% |
| Q1 2022 | $2,231,000 | +40.7% | 193,709 | +21.9% | 0.00% | – |
| Q4 2021 | $1,586,000 | -32.7% | 158,869 | -12.0% | 0.00% | -100.0% |
| Q3 2021 | $2,357,000 | -58.5% | 180,445 | -37.8% | 0.00% | -50.0% |
| Q2 2021 | $5,684,000 | -13.5% | 290,270 | -5.9% | 0.00% | 0.0% |
| Q1 2021 | $6,574,000 | -34.9% | 308,573 | -9.2% | 0.00% | -50.0% |
| Q4 2020 | $10,098,000 | +39.2% | 339,657 | +1.4% | 0.00% | +33.3% |
| Q3 2020 | $7,256,000 | +0.9% | 334,814 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $7,194,000 | +76.1% | 322,635 | +20.1% | 0.00% | +50.0% |
| Q1 2020 | $4,086,000 | -34.7% | 268,531 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $6,258,000 | +11.7% | 272,546 | +5.0% | 0.00% | 0.0% |
| Q3 2019 | $5,603,000 | +19.0% | 259,514 | +21.3% | 0.00% | 0.0% |
| Q2 2019 | $4,708,000 | +75.8% | 214,017 | +119.3% | 0.00% | +100.0% |
| Q1 2019 | $2,678,000 | +85.1% | 97,611 | +81.4% | 0.00% | 0.0% |
| Q4 2018 | $1,447,000 | – | 53,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |